Showing results (211-220 of 344) with videos related to
Sort By:
Pageof 35
Journal of Human Genetics|October 19, 2025
Germline or somatic mutations in genes encoding microRNAs as biomarkers predicting the risk of adult T-cell leukemia/lymphomaShimon Nakashima, Masataka Nakano, Tatsuki Fukami, et al.British Journal of Haematology|April 23, 2025
Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphomaTomotaka Suzuki, Keiichiro Fujii, Naohiro Matsunaga, et al.Journal of Biochemistry|November 10, 2023
Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradationMuneshige Tokugawa, Yasumichi Inoue, Hiromasa Aoki, et al.Cancer Science|June 26, 2003
Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasiaKazuhisa Miura, Shinsuke Iida, Ichiro Hanamura, et al.Cancer Science|March 25, 2022
Two-year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemiaNaohiro Sekiguchi, Shinya Rai, Wataru Munakata, et al.International Journal of Hematology|January 31, 2015
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapyHaruhito Totani, Shigeru Kusumoto, Takashi Ishida, et al.Cancer Science|July 9, 2020
A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemiaNaohiro Sekiguchi, Shinya Rai, Wataru Munakata, et al.Scientific Reports|May 12, 2023
Overexpression of GRK2 in vascular smooth muscle leads to inappropriate hypertension and acute heart failure as in clinical scenario 1Hiroki Yano, Kenji Onoue, Shiho Tokinaga, et al.British Journal of Haematology|April 26, 2017
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myelomaShotaro Tatekawa, Yoshiaki Chinen, Masaki Ri, et al.Cancer Research|October 2, 2014
Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myelomaYoshiaki Chinen, Junya Kuroda, Yuji Shimura, et al.Pageof 35